Clinical Trials Directory

Trials / Unknown

UnknownNCT06331793

Pulsed Electromagnetic Fields for Analgesia Post Mastectomy

Use of a Wearable Device Which Generates an Electromagnetic Pulsed Field for Postoperative Analgesia of Mastectomies

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
160 (estimated)
Sponsor
European Institute of Oncology · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Study aim is to test AlgoCare, a device that uses the technology PEMF (Pulsed ElectroMagnetic Fields) for the treatment of postoperative pain in oncological breast surgery, in order to demonstrate that the use of Algocare in the postoperative period allows for a reduction in pain intensity in terms of Numerical Rating Scale (NRS) score and use of analgesic drugs.

Detailed description

The treatment of postoperative pain is a priority issue for both the doctor and the patient. Obtaining adequate analgesia in the first postoperative days, in fact, is essential for the patient's comfort, but also to promote and accelerate functional recovery and prevent chronic pain, which in the case of breast surgery has a high incidence (20-60 %). The use of pulsed electromagnetic fields (PEMF) for the treatment of pain and inflammation has been widely studied and validated. Study aim is to test AlgoCare, a device that uses the technology PEMF (Pulsed ElectroMagnetic Fields), for the treatment of postoperative pain in oncological breast surgery. This is a field of application in which this technique analgesic has never been tested, but in which it could prove valid within a multimodal analgesia protocol, as the pain caused by this type of intervention is predominantly parietal and resulting from tissue trauma caused by the surgical wound. AlgoCare is a non-invasive and non-pharmacological device, developed specifically for treatment of post-operative inflammation and pain, CE certified and registered with the Ministry of Health. It emits a pulsed radio frequency electromagnetic field at 27.1 MHz, a frequency already studied and approved for medical use.

Conditions

Interventions

TypeNameDescription
DEVICEActive AlgoCareDevice that emits Pulsed Electromagnetic Fields
DEVICENon-active AlgoCareDevice that doesn't emit Pulsed Electromagnetic Fields

Timeline

Start date
2023-05-09
Primary completion
2024-12-31
Completion
2024-12-31
First posted
2024-03-26
Last updated
2024-03-26

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06331793. Inclusion in this directory is not an endorsement.